He Hong-Qiu, Ma Xiao-Hui, Liu Bin, Zhang Xiao-Yi, Chen Wei-Zu, Wang Cun-Xin, Cheng Shao-Hui
College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100022, China.
Acta Pharmacol Sin. 2007 Jun;28(6):811-7. doi: 10.1111/j.1745-7254.2007.00561.x.
To develop a high-throughput real-time assay based on molecular beacons to monitor the integrase 3'-processing reaction in vitro and apply it to inhibitor screening.
The recombinant human immunodeficiency virus (HIV)-1 integrase (IN) is incubated with a 38 mer oligonucleotide substrate, a sequence identical to the U5 end of HIV-1 long terminal repeats (LTR). Based on the fluorescence properties of molecular beacons, the substrate is designed to form a stem-loop structure labeled with a fluorophore at the 5' end and a quencher at the 3' end. IN cleaves the terminal 3'-dinucleotide containing the quencher, resulting in an increase in fluorescence which can be monitored on a spectrofluorometer. To optimize this assay, tests were performed to investigate the effects of substrates, enzyme and the metal ion concentrations on the IN activity and optimal parameters were obtained. Moreover, 2 IN inhibitors were employed to test the performance of this assay in antiviral compound screening.
The fluorescent intensity of the reaction mixture varies linearly with time and is proportional to the velocity of the 3'-processing reaction. Tests were performed and the results showed that the optimal rate was obtained for a reaction mixture containing 50 mg/L recombinant HIV-1 IN, 400 nmol/L substrate, and 10 mmol/L Mn(2+). The IN 3'-processing reaction under the optimal conditions showed a more than 18-fold increase in the fluorescence intensity compared to the enzyme-free control. The IC50 values of the IN inhibitors obtained in our assay were similar to the values obtained from a radiolabeled substrate assay.
Our results demonstrated that this is a fast, reliable, and sensitive method to monitor HIV IN 3'-processing reaction and that it can be used for inhibitor screening.
开发一种基于分子信标的高通量实时检测方法,用于体外监测整合酶3'-加工反应,并将其应用于抑制剂筛选。
将重组人免疫缺陷病毒(HIV)-1整合酶(IN)与一个38聚体寡核苷酸底物一起孵育,该底物序列与HIV-1长末端重复序列(LTR)的U5末端相同。基于分子信标的荧光特性,将底物设计成一种茎环结构,在5'端标记有荧光团,在3'端标记有淬灭剂。IN切割含有淬灭剂的末端3'-二核苷酸,导致荧光增强,可在荧光分光光度计上进行监测。为优化该检测方法,进行了实验以研究底物、酶和金属离子浓度对IN活性的影响,并获得了最佳参数。此外,使用2种IN抑制剂来测试该检测方法在抗病毒化合物筛选中的性能。
反应混合物的荧光强度随时间呈线性变化,并且与3'-加工反应的速度成正比。进行的实验结果表明,对于含有50 mg/L重组HIV-1 IN、400 nmol/L底物和10 mmol/L Mn(2+)的反应混合物,可获得最佳反应速率。在最佳条件下的IN 3'-加工反应与无酶对照相比,荧光强度增加了18倍以上。在我们的检测中获得的IN抑制剂的IC50值与从放射性标记底物检测中获得的值相似。
我们的结果表明,这是一种快速、可靠且灵敏的监测HIV IN 3'-加工反应的方法,可用于抑制剂筛选。